The tipping point

judges in the trio of huge, crisis bankruptcies rushed the cases through to approve so-called section 363 sales. This has some lawyers worried about the future of creditors' due process rights

M&A activity may have stalled during the first half of the year, but deal lawyers still had plenty to talk about.

The healthcare sector was hot in July, with two of the three largest deals of the month: Sanofi-Aventis agreed to pay Merck $4 billion for joint venture Merial, and Bristol-Myers Squibb is buying Medarex for $2.4 billion.

Despite tapping Evercore's Roger Altman and Morgan Stanley's Ruth Porat, who advised the Fed on AIG, troubled CIT still failed to secure government assistance.

With Agilent, Amazon.com and IBM making acquisitions, there is no lack of work for technology advisers.

As bank failures accelerate, the FDIC has had to get creative to handle the disposals. Enter the veterans of bank failures past.

Bob Nardelli ran Chrysler for Cerberus. Now he's overseeing operations of other Cerberus portfolio companies.

Moelis & Co. continues to expand in Europe with a goal of becoming a full service investment bank.

Quinton Jay joins Sam Bronfman's wine-focussed mezzanine fund Bacchus Capital.

Geithner yells at bank regulators, but they keep opposing the administration's overhaul plans anyway.

A conversation with former Pfizer, now University of California, San Francisco, biotech veteran Corey Goodman.

As Arcandor's self-administration unravels, does debtor-in-possession bankruptcy have a future in Germany? One expert says that because of the Arcandor failure, such cases will become even more rare.

PE firms are marketing their portfolio company IPOs to raise cash, not create a profitable exit. Will investors bite?

Many predicted a booming market in LP private equity assets. It hasn't happened — yet.

In a buyer's market, scrutiny of both risks and business basics is at an all-time high. That can mean deeper looks into everything from customer and supplier relationships to the provenance of key patents.

Amid unprecedented turmoil in venture portfolios, one cash-rich startup buys out its VC backer.

In a complex maneuver, KKR wipes out debt in three CLO funds to improve liquidity and help itself.

Oracle's proposed $7.4 billion acquisition of Sun is on track for summer close; Addax Petroleum's $8.5 billion purchase by Sinopec also nears close and more.

Wall Street is a living embodiment of what Joseph Schumpeter famously called creative destruction.

Euphoria produced anxieties as the flood of liquidity spawned a variety of new life forms, many of them crawled from the stuffed-to-the-gills hedge fund world.

Aggressive and unrepentant ignorance seems to be the order of the day. If you don't know what the Fed does, how can you blame it for anything?

Things may look dire out there for media properties supported by advertising. But Veronis Suhler is upbeat.

Regardless of when law firms recover, associates will feel the impact of the recession for a long time to come. Morgan, Lewis & Bockius has recently canceled its 2010 summer associates program and has said it would put an end to lockstep compensation for associates.

The FTC tries finally to end Generics' pay-for-delay Deals with branded pharma. But will it survive the healthcare reform?

A down market is often the best time to acquire a business, snap up strategic assets, or simply recapitalize or restructure for the future

Consumer prices have risen for two consecutive months and commodity prices may also increase.

An amendment to the German Foreign Trade Act authorizes the federal government to prohibit certain foreign investors from buying stakes of 25% or more in German companies if such acquisition would endanger 'public order' or 'public security.'